Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2010 Apr 28;5(4):10.1371/annotation/54fad81d-c975-4b30-bb2b-249650ec3d66. doi: 10.1371/annotation/54fad81d-c975-4b30-bb2b-249650ec3d66

Correction: Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy

Martin Lubin, Adam Lubin
PMCID: PMC2860973

This sentence (in Discussion section, "Toxicity of MTA in vivo" subsection) contains an incorrect unit and should appear as follows: "MTA has also been administered orally to ten humans at 1,600 mg daily, for one month, and seems to be nontoxic [30]."

Footnotes

Competing Interests: No competing interests declared.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES